These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 4074571

  • 1. [Long-term evaluation of tiapride in patients with various forms of dyskinesia].
    Nakajima Y, Kondo T, Narabayashi H.
    No To Shinkei; 1985 Oct; 37(10):1013-9. PubMed ID: 4074571
    [Abstract] [Full Text] [Related]

  • 2. [Clinical trial of tiapride in patients with dyskinesia (author's transl)].
    Chouza C, Romero S, Lorenzo J, Camano JL, Fontana AP, Alterwain P, Cibils D, Gaudiano J, Feres S, Solana J.
    Sem Hop; 1982 Mar 25; 58(12):725-33. PubMed ID: 6283645
    [Abstract] [Full Text] [Related]

  • 3. [Tiapride in persistent dyskinesias following long-term L-dopa for parkinsonism].
    Arlazoroff A, Flechtir S, Goldexberg E, Bleicher Z, Barber Y.
    Harefuah; 1985 Mar 01; 108(5):227-9. PubMed ID: 4007677
    [No Abstract] [Full Text] [Related]

  • 4. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
    Perényi A, Arató M, Bagdy G, Frecska E, Szücs R.
    J Clin Psychiatry; 1985 Jun 01; 46(6):229-31. PubMed ID: 2860098
    [Abstract] [Full Text] [Related]

  • 5. [Two cases of buccolingual dyskinesia treated with tiapride (author's transl)].
    Robillard J.
    Sem Hop; 1985 Jun 01; 56(41-42):1731-2. PubMed ID: 6255602
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of dyskinesias with tiapride (author's transl)].
    Kocher R, Hobi V.
    Sem Hop; 1985 Jun 01; 56(47-68):2033-4. PubMed ID: 6109379
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutical approach to involuntary movements (author's transl)].
    Allain H, Sabouraud O.
    Sem Hop; 1985 Jun 01; 55(5-6):262-4. PubMed ID: 219537
    [Abstract] [Full Text] [Related]

  • 8. The benzamide tiapride: treatment of extrapyramidal motor and other clinical syndromes.
    Dose M, Lange HW.
    Pharmacopsychiatry; 2000 Jan 01; 33(1):19-27. PubMed ID: 10721880
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of abnormal movements of extrapyramidal origin with tiapride].
    Ferrari G, Lovaste MG, Girardi P, Boninsegna C.
    Riv Neurol; 1981 Jan 01; 51(3):125-33. PubMed ID: 7256107
    [Abstract] [Full Text] [Related]

  • 10. Extrapyramidal effects of benzamides.
    Chouza C, Caamano JL, Romero S, Lorenzo J, Feres S.
    Adv Biochem Psychopharmacol; 1985 Jan 01; 40():43-6. PubMed ID: 4025040
    [No Abstract] [Full Text] [Related]

  • 11. [Tiapride therapy of centrally produced dyskinesia. Examination of the serum levels of protein, LH and FSH (author's transl)].
    Aschoff JC, Claus D, Hetzel WD.
    Arzneimittelforschung; 1982 Jan 01; 32(3):286-9. PubMed ID: 6805485
    [Abstract] [Full Text] [Related]

  • 12. [Oral dyskinesis, facial dystonia].
    Nakamura S, Akiguchi I.
    Nihon Rinsho; 1993 Nov 01; 51(11):2978-82. PubMed ID: 8277580
    [Abstract] [Full Text] [Related]

  • 13. [Tiapride in the treatment of irreversible tardive dyskinesia--initial experiences].
    Leblhuber F, Reisecker F, Bengesser G.
    Z Gerontol; 1987 Nov 01; 20(1):49-51. PubMed ID: 2883781
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.
    Lundblad M, Usiello A, Carta M, Håkansson K, Fisone G, Cenci MA.
    Exp Neurol; 2005 Jul 01; 194(1):66-75. PubMed ID: 15899244
    [Abstract] [Full Text] [Related]

  • 15. Tiapride in levodopa-induced involuntary movements.
    Lees AJ, Lander CM, Stern GM.
    J Neurol Neurosurg Psychiatry; 1979 Apr 01; 42(4):380-3. PubMed ID: 458486
    [Abstract] [Full Text] [Related]

  • 16. [Tiapride (Tiapridal) in tardive dyskinesia: another Beelzebub?].
    Nolen WA, Moleman P, Loonen AJ.
    Ned Tijdschr Geneeskd; 1982 Oct 30; 126(44):2022-3. PubMed ID: 7177212
    [No Abstract] [Full Text] [Related]

  • 17. [Value of sulpiride and tiapride in geriatrics. Antagonism between Parkinson disease and chorea].
    Graux P, Durocher AM.
    Lille Med; 1979 Nov 17; Suppl 1():107-8. PubMed ID: 553214
    [No Abstract] [Full Text] [Related]

  • 18. [Therapeutic use of tiapride in movement disorders].
    Mathé JF, Cler JM, Venisse JL.
    Sem Hop; 1978 May 17; 54(13-16):517-20. PubMed ID: 211595
    [Abstract] [Full Text] [Related]

  • 19. Tiapride in tardive dyskinesia.
    Murphy DJ, Hughes G, Shaw GK.
    Psychopharmacol Bull; 1982 Oct 17; 18(4):13-6. PubMed ID: 7156275
    [No Abstract] [Full Text] [Related]

  • 20. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.
    Brain; 2008 Dec 17; 131(Pt 12):3380-94. PubMed ID: 18952677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.